SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹263 Cr | ₹173 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹173 Cr |
| Mar2023 | ₹176 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹154 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 52.53 | |
| Mar2024 | ₹173 Cr | -1.85 | |
| Mar2023 | ₹176 Cr | -15.92 | |
| Mar2022 | ₹209 Cr | 36.16 | |
| Mar2021 | ₹154 Cr | - | |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹5,785.1 Cr | 6.8% | 5.7% | 5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,477.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,934.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,469.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,250.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,038.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 6.8% |
5.7% |
5.2% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses